Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PG 2

Drug Profile

PG 2

Alternative Names: Injectable astragalus polysaccharide; PG2; PHN011; PHN012; PHN013; PHN014; PHN015; Polysaccharides of Astragalus membranaceus; XueBao

Latest Information Update: 10 May 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pharmagenesis
  • Developer Pharmagenesis; PhytoHealth
  • Class Phytotherapies; Polysaccharides
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Idiopathic thrombocytopenic purpura
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Fatigue; Leucopenia
  • Phase II Stroke
  • No development reported Idiopathic thrombocytopenic purpura

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 01 Mar 2018 PhytoHealth Corporation initiates a phase II trial for Fatigue (Cancer related) in Taiwan (NCT03314805)
  • 19 Oct 2017 PhytoHealth Corporation plans a phase II trial for Fatigue (Cancer related) in Taiwan (NCT03314805)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top